Filing summary
Identity note: The supplied filing is Atlas Crest Investment Corp.’s Form 10-Q, not an Archer Aviation Inc. filing. It reports the period from August 26, 2020 (inception) through September 30, 2020; the financial statements are unaudited.
Business context and reporting period
Atlas Crest was a newly formed blank-check company (SPAC) seeking a business combination. As of September 30, it had not begun operations, selected a target, or held substantive discussions with a prospective target. Management described broad potential sectors of interest, including media, online gaming/sports betting, fintech/payments, healthcare, business services, and disruptive consumer businesses.
Financial results and liquidity
| Metric | Reported amount |
|---|---|
| Cash at September 30, 2020 | $145,797 |
| Total assets | $384,654, including $238,857 of deferred offering costs |
| Total liabilities | $362,222, including a $300,000 related-party note and $62,222 of accrued offering costs |
| Stockholders’ equity | $22,432 |
| Revenue | None; the company had not commenced operations |
| Net loss | $2,568, entirely from formation and operating costs |
| Net cash used in operating activities | $2,568 |
| Net cash provided by financing activities | $148,365 |
Margins, operating cash flow after a business combination, and debt ratios are not meaningful for this pre-operational SPAC. The $300,000 non-interest-bearing sponsor note was repaid at the IPO closing on October 30, 2020. No prior comparable operating period is presented.
Material developments and outlook
- Subsequent IPO: On October 30, 2020, the company sold 50 million units at $10 each, raising $500 million gross, and sold 8 million private placement warrants for $12 million gross. The filing says $500 million was placed in the trust account. These are post-quarter events, not September 30 balances.
- The company had 24 months from the IPO closing to complete a business combination; otherwise, it generally must redeem public shares and liquidate. Public shareholders may redeem shares in connection with a combination, subject to the filing’s terms. Warrants could expire worthless if no combination is completed.
- Management expected about $800,000 of IPO proceeds to remain outside the trust for search, transaction, reporting, and general expenses, and estimated annual Delaware franchise taxes of up to $200,000. These are estimates, not September 30 cash figures.
- Management anticipated no need for additional pre-combination funding under its estimates, but warned that actual search and transaction costs or a larger-than-expected cash requirement could create a funding shortfall. Sponsor-related working-capital loans were possible but not committed.
- A business-combination marketing fee of 3.5% of offering gross proceeds—$17.5 million, subject to adjustment for the over-allotment—would be payable upon completion of a combination. The Sponsor also receives $10,000 monthly for administrative support after the IPO.
Risks, contingencies, and other disclosures
- Management said COVID-19 could adversely affect the company’s financial position, operations, or target search, but the impact was not determinable.
- The filing identifies the possibility that negative interest rates could reduce trust assets and the per-share redemption amount below $10.
- Additional equity or debt financing for a combination could dilute shareholders or increase leverage and related financial risks. The filing also describes potential sponsor indemnification for certain third-party claims against the trust, subject to exceptions and limitations.
- No legal proceedings or off-balance-sheet arrangements were reported. Management concluded disclosure controls were effective as of September 30, 2020.
Important facts for investors to verify
- Confirm the issuer: this filing is for Atlas Crest Investment Corp., not Archer Aviation Inc.
- Review the IPO and trust-account amounts, including the distinction between post-quarter IPO proceeds and September 30 reported cash.
- Verify the applicable business-combination deadline, redemption provisions, warrant terms, and any subsequent transaction filings.
- Assess the potential effect of sponsor-related fees, founder-share conversion and dilution, and any future financing on public shareholders.
- Compare these inception-period results with subsequent filings; this 10-Q provides no prior comparable operating period or meaningful operating outlook.